Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [(18)F]-PET Imaging in a Primate Brain

Journal of Medicinal Chemistry
Emmanuel DeauGérald Guillaumet

Abstract

We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo[d]imidazol-2(3H)-ones, imidazo[4,5-b]pyridin-2(3H)-ones, imidazo[4,5-c]pyridin-2(3H)-ones, benzo[d]oxazol-2(3H)-ones, oxazolo[4,5-b]pyridin-2(3H)-ones and N,N'-dialkylated benzo[d]imidazol-2(3H)-ones. These compounds were evaluated against 5-HT7R, 5-HT2AR, 5-HT1AR, and 5-HT6R as potent dual 5-HT7/5-HT2A serotonin receptors ligands. A thorough study of the structure-activity relationship of the aromatic rings and their substituents, the alkyl chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1H-benzo[d]imidazol-2(3H)-one (79) and 1-(6-(4-(4-fluorobenzoyl)piperidin-1-yl)hexyl)-1H-benzo[d]imidazol-2(3H)-one (81) were identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, KB = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, KB = 0.6 and 16 nM, respectively) signaling pathways of 5-HT7R and 5-HT2AR. Both antagonists crossed the blood-brain barrier as evaluated with [(18)F] radiolabeled compounds [(18)F]79 and [(18)F]81 in a primate's central nervous system using positron emission tomography. Both radioligands showed standard uptake values ranging from 0.8 to 1.1, a good plasmat...Continue Reading

References

Aug 1, 1991·Journal of Medicinal Chemistry·J L MalleronC Huon
Oct 1, 1972·Journal of Medicinal Chemistry·J G Topliss
Apr 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R ArmitageH P Roffwarg
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M RuatJ C Schwartz
Sep 1, 1995·Human Reproduction·S M el-ShouraE M Elmalik
Oct 24, 1996·European Journal of Pharmacology·E HeuilletJ C Blanchard
Feb 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·P SeemanH H Van Tol
Feb 5, 1999·Naunyn-Schmiedeberg's Archives of Pharmacology·D L NelsonR A Glennon
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
May 24, 2000·British Journal of Pharmacology·J J HaganD R Thomas
Mar 28, 2002·Pharmacology & Therapeutics·J R RaymondM N Garnovskaya
Apr 12, 2002·Current Medicinal Chemistry·M L López-RodríguezA Viso
Oct 24, 2002·Bioorganic & Medicinal Chemistry Letters·Ian T ForbesDavid R Thomas
Dec 7, 2002·Bioorganic & Medicinal Chemistry Letters·Chika KikuchiMasao Koyama
Jan 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·P B HedlundJ G Sutcliffe
Mar 20, 2003·Bioorganic & Medicinal Chemistry Letters·Ian T ForbesDavid R Thomas
May 24, 2003·Neuropharmacology·M R GuscottP H Hutson
Jun 19, 2003·British Journal of Pharmacology·David R ThomasIan T Forbes
Dec 12, 2003·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Marc LaruelleYiyun Huang
Dec 12, 2003·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Rikki N Waterhouse
Apr 14, 2004·The European Journal of Neuroscience·Amanda J RobertsPeter B Hedlund
Jul 21, 2004·Bioorganic & Medicinal Chemistry Letters·Ronald J MattsonGraham Johnson
Jun 7, 2005·Behavioural Brain Research·Georgina S Perez-García, A Meneses
Jul 5, 2005·Neuropharmacology·Cécile MahéPhilippe Schoeffter
Jul 16, 2005·Biological Psychiatry·Peter B HedlundJ Gregor Sutcliffe
Aug 27, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Elena KvachninaEvgeni G Ponimaskin

❮ Previous
Next ❯

Citations

Jun 5, 2018·Angewandte Chemie·Antonio Del VecchioDavide Audisio
May 6, 2017·Scientific Reports·Adam S HogendorfAndrzej J Bojarski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.